SEC Company Response from BIOSPECIFICS TECHNOLOGIES CORP (CIK 0000875622) — Jul 15, 2020
BIOSPECIFICS TECHNOLOGIES CORP (CIK 0000875622)
Date: July 15, 2020 · CIK: 0000875622 · Accession: 0001193125-20-193282
AI Filing Summary & Sentiment
File numbers found in text: 333-239484
Letter
BioSpecifics Technologies Corp.
2 Righter Parkway, Suite 200
Wilmington, DE 19803
July 15, 2020
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Ada Sarmento
Re: BioSpecifics Technologies Corp.
Registration Statement on Form S-3
Filed June 26, 2020
File No. 333-239484
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, BioSpecifics Technologies Corp. hereby requests acceleration of the effective date of the above referenced registration statement, as amended, so that such registration statement may become effective at 4:30 p.m. (Washington, D.C. time) on July 17, 2020, or as soon as practicable thereafter.
BIOSPECIFICS TECHNOLOGIES CORP.
By:
/s/ Joseph Truitt
Name:
Joseph Truitt
Title:
Chief Executive Officer
Show Raw Text
CORRESP 1 filename1.htm CORRESP BioSpecifics Technologies Corp. 2 Righter Parkway, Suite 200 Wilmington, DE 19803 July 15, 2020 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Ada Sarmento Re: BioSpecifics Technologies Corp. Registration Statement on Form S-3 Filed June 26, 2020 File No. 333-239484 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, BioSpecifics Technologies Corp. hereby requests acceleration of the effective date of the above referenced registration statement, as amended, so that such registration statement may become effective at 4:30 p.m. (Washington, D.C. time) on July 17, 2020, or as soon as practicable thereafter. BIOSPECIFICS TECHNOLOGIES CORP. By: /s/ Joseph Truitt Name: Joseph Truitt Title: Chief Executive Officer